Cytogenetic effects of hexavalent chromium in Bulgaria.
Nersesyan
A K
AK
D024422:Aneugens / Q000009:adverse effects*; D002274:Carcinogens, Environmental / Q000009:adverse effects*; D002478:Cells, Cultured; D002857:Chromium / Q000009:adverse effects*; D002869:Chromosome Aberrations / Q000139:chemically induced*; D020732:Cytogenetic Analysis; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D019570:Inhalation Exposure; D008214:Lymphocytes / Q000187:drug effects / Q000502:physiology; D008297:Male; D048629:Micronuclei, Chromosome-Defective / Q000187:drug effects / Q000235:genetics; D015162:Micronucleus Tests; D009061:Mouth Mucosa / Q000166:cytology / Q000187:drug effects; D016296:Mutagenesis; D016273:Occupational Exposure; D012854:Sister Chromatid Exchange / Q000187:drug effects / Q000235:genetics
D024422:Aneugens; D002274:Carcinogens, Environmental; D002857:Chromium; C074702:chromium hexavalent ion